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Abstract 25 
 26 
Objective: We performed a systematic review, meta-analysis and meta-regression of exercise 27 
studies that sought to determine the relationship between cardiac troponin (cTn) and left 28 
ventricular (LV) function. The second objective was to determine how study-level and 29 
exercise factors influenced the variation in the body of literature.  30 
 31 
Data Sources: A systematic search of Pubmed Central, Science Direct, SPORTDISCUS, and 32 
MEDLINE databases. 33 
 34 
Eligibility Criteria: Original research articles published between 1997-2018 involving 35 
>30mins of continuous exercise, measuring cardiac troponin event rates and either LV 36 
ejection fraction (LVEF) or the ratio of the peak early (E) to peak late (A) filling velocity 37 
(E/A ratio).   38 
 39 
Design: Random-effects meta-analyses and meta-regressions with four a priori determined 40 
covariates (age, exercise heart rate [HR], duration, mass).  41 
 42 
Registration: The systematic search strategy was registered on the PROSPERO database 43 
(CRD42018102176).  44 
 45 
Results: Pooled cTn event rates were evident in 45.6% of participants (95% CI = 33.6 – 46 
58.2%); however, the overall effect was non-significant (P>0.05). There were significant 47 
(P<0.05) reductions in E/A ratio of – 0.38 (SMD = -1.2, 95% CI [-1.4, -1.0]), and LVEF of -48 
2.02% (SMD = -0.38, 95%CI [-0.7, -0.1]) pre to post-exercise. Increased exercise HR was a 49 
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significant predictor of troponin release and E/A ratio. Participant age was negatively 50 
associated with cTn release. There was a significant negative association between E/A ratio 51 
with increased rates of cTn release (P < 0.05). 52 
 53 
Conclusions: High levels of statistical heterogeneity and methodological variability exist in 54 
the majority of EICF studies. Our findings show that exercise intensity and age are the most 55 
powerful determinants of cTn release. Diastolic function is influenced by exercise HR and 56 
cTn release, which implies that exercise bouts at high intensities are enough to elicit cTn 57 
release and reduce LV diastolic function. Future EICF studies should 1) utilise specific 58 
echocardiographic techniques such as myocardial speckle tracking, 2) ensure participants are 59 
euhydrated during post-exercise measurements, and 3) repeat measures in the hours following 60 
exercise to assess symptom progression or recovery. It is also recommended to further 61 
explore the relationship between aging, training history, and exercise intensity on cTn release 62 
and functional changes. 63 
 64 
 65 
Key Points: 
 The magnitude of exercise induced reductions in diastolic function is related to 
troponin event rate. 
 Higher average exercise heart rates are associated with an increased troponin event 
rate and greater reductions in diastolic function. 
 Increased age leads to a lower troponin event rate and reduced average exercise 
heart rates. This may have important implications for older/veteran athletes 
participating in prolonged endurance events. 
 66 
 67 
 68 
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List of Abbreviations 69 
CI – Confidence intervals 70 
CS – Circumferential strain 71 
cTn – Cardiac troponin 72 
E/A Ratio – Early to late diastolic filling velocity ratio 73 
EICF – Exercise induced cardiac fatigue 74 
HR – Heart rate 75 
LS – Longitudinal strain 76 
LV – Left ventricle 77 
LVEF – Left ventricular ejection fraction 78 
PSE – Prolonged strenuous exercise 79 
RS – Radial strain 80 
RV – Right ventricle 81 
V
·
O2 – Oxygen consumption 82 
hs-cTnT – High-sensitivity cardiac troponin T  83 
hs-cTnI – High-sensitivity cardiac troponin I 84 
cTnT – Cardiac troponin T assay 85 
cTnI-Beckman - Cardiac troponin I assays manufactured by Beckman Coulter 86 
cTnI-Siemens - Cardiac troponin I assays manufactured by Siemens  87 
 88 
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1. Introduction 89 
 90 
Prolonged strenuous endurance exercise (PSE) is associated with altered cardiac physiology, 91 
that often manifests as both transient alterations in cardiac function and detectable levels of 92 
biomarkers, most commonly cardiac troponin (cTn) in the peripheral circulation (1). In some 93 
instances, acute measurements of systolic and diastolic left ventricular (LV) function 94 
following PSE measured via echocardiography are transiently reduced compared to resting 95 
values (1-32). This exercise induced cardiac fatigue (EICF) typically persists for 12-48 hours 96 
post-exercise before the heart recovers and functional measures return to baseline levels (2-97 
4). Similarly, immediately post-exercise cTn levels in the blood of endurance athletes have 98 
been reported to exceed clinical detection thresholds for the diagnosis of acute myocardial 99 
infarction (5-8), but typically return to baseline within 72 hours post-exercise (9). Currently, 100 
there is no consensus on whether the process of biomarker release and transient reductions in 101 
ventricular function is a benign, pathological or adaptive response. The inclusion of follow-102 
up measurements during the recovery process from exercise may elucidate the nature of 103 
EICF; however, this is not always included in study design. Frequently, only single 104 
measurements immediately post-exercise are performed and progression to the restoration of 105 
normal cardiac function following exercise warrants investigation. While often measured 106 
together (1, 8, 10-28), the extent of a possible relationship between cTn release and cardiac 107 
function is unclear, with the majority of studies that measure both variables reporting no 108 
correlations between the two (5, 6). It is also still unclear from individual studies whether the 109 
release of cTn indicates persistent functional alterations to the myocardium following 110 
exercise (9), and how the time course of exercise-induced cTn release differs from coronary 111 
events.  112 
 113 
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Of particular relevance to athletes and coaches is the influence of exercise intensity, mode 114 
and duration on EICF and cTn release. Both significant and non-significant effects of 115 
exercise have been reported following varied exercise modes at both ends of the 116 
intensity/duration spectrum (15, 29). Indeed, there is evidence of EICF and cTn release 117 
following exercise bouts as short as 30 minutes at high relative intensities (30), and from 118 
exercise bouts lasting as long as 10-24 hours (6, 31, 32). However, the between-study event 119 
rate and participant responses are varied, with studies rarely reporting declines in all cardiac 120 
functional variables and one hundred percent incidence of biomarker release across all their 121 
participants. In terms of exercise and participant factors that play a role, Shave and colleagues 122 
reported that cTn event rates were higher with increased participant body-mass and lower 123 
with increased exercise duration, and that there was no effect of exercise mode (33). In their 124 
meta-analysis of LV function pre to post exercise, Middleton and colleagues (4) observed that 125 
increased exercise duration resulted in greater reductions in post-exercise left ventricular 126 
ejection fraction (LVEF) and no effects of training history, age or body mass.  127 
Importantly, exercise intensity has not yet been meta-analysed as a moderator variable in the 128 
body of EICF research, although the most recent published papers suggest that cTn release 129 
and temporarily reduced diastolic function is more readily triggered by short, high-intensity 130 
exercise (34). Systolic function appears to be more resilient to exercise and has mostly been 131 
reported to decline following long-duration exercise performed at lower relative intensities, 132 
such as Ironman triathlon or ultra-marathon races (9).  133 
 134 
The collective findings of the body of published studies do not demonstrate a clear link 135 
between cTn release and EICF, as the results are largely varied. The variation in the findings 136 
may be explained by the influence of study and participant level factors, such as the timing of 137 
post-exercise data collection, blinding sonographers to the trial conditions or unaccounted for 138 
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participant dehydration. A systematic review of studies measuring both cTn and EICF 139 
variables would provide recommendations for future studies of cardiac function and cardiac 140 
biomarker release following exercise (4, 33). Additionally, meta-analysis of exercise 141 
characteristics (mode, duration and intensity) as moderators in a meta-regression would 142 
provide evidence towards a mechanistic explanation of EICF and biomarker release. 143 
Therefore, the aim of this study was to conduct a systematic review and meta-analysis of 144 
studies that measured both EICF and cTn following endurance exercise, and to elucidate the 145 
influence of both exercise and participant factors. 146 
 147 
2. Materials and Methods 148 
 149 
This meta-analysis was performed according to PRISMA guidelines. As such, we conducted 150 
a literature search for peer-reviewed, English-language journal articles examining the effects 151 
of exercise on both cTn release and cardiac function, as measured by echocardiography. The 152 
search strategy was registered on the PROSPERO database prior to being conducted (registry 153 
number: CRD420181021760. The full search strategy is shown in Figure 1. 154 
 155 
2.1 Search Strategy 156 
 157 
Sources used for this search were SPORTDiscus, PubMed Central, Science Direct and 158 
MEDLINE. The key words were cardiac troponin, endurance exercise, and 159 
echocardiography. The initial search was undertaken by 2 independent researchers (JD, 160 
JOD), who selected the studies according to the search strategy and based on the inclusion 161 
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and exclusion criteria shown below. After the initial database search, the titles and abstracts 162 
of all studies identified by the database search were screened for suitability. The reference 163 
lists from published papers were also searched for relevant studies that did not appear in the 164 
database search, as well as papers that cited the selected studies were reviewed for inclusion. 165 
The most recent search for current publications was conducted in the month of July, 2018. 166 
 167 
2.2 Inclusion and Exclusion Criteria 168 
 169 
1) Blood and echo measurements taken prior-to exercise and within 1 hour of cessation 170 
of exercise. Studies falling outside of this range were excluded. The majority of 171 
studies returned in the initial literature search collected blood as close to immediately 172 
after exercise. Cardiac troponin is released in phases following exercise, therefore a 1-173 
hour cut-off was imposed to attempt to standardise the release phase.  174 
2) Two-dimensional echocardiographic measurement of either E/A ratio or LVEF or 175 
provided data from which they could be calculated. 176 
3) Taken venous blood samples for cardiac troponin T or I (cTn) or high-sensitivity cTn 177 
T or I.  178 
4) Reporting the number of positive cTn tests pre and post-exercise. 179 
5) Studies involving pharmacological or dehydration interventions were excluded. 180 
6) Only studies involving continuous exercise such as running or cycling were chosen. 181 
7) Studies involving team sports were excluded. 182 
8) Available information on exercise mode and participant training status. 183 
9) For inclusion into the regression analysis, studies must have reported average exercise 184 
heart rate (HR), exercise duration, participant age, and mass.  185 
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2.3 Quality Assessment 186 
 187 
The quality of the selected studies was independently rated by JD and JOD, using a modified 188 
Cochrane risk of bias table (see Supplementary Table 1). Any disputes on study suitability or 189 
quality were discussed with a third researcher (JW). We used selective reporting (C), other 190 
bias (D), blinding of participants and personnel (E), and blinding of outcome assessment (F) 191 
as the main domains. Random sequence generation (A) and allocation concealment (B) were 192 
not assessed due to the nature of the exercise interventions. Studies were given a positive 193 
score if accounting for one of the main domains and negative scores were given when the 194 
criteria were not met. Full descriptions of the criteria are shown in the supplementary file. 195 
Where studies failed to describe any of the details required by the criteria, we assigned a 196 
neutral score when the criteria were not relevant to the study design. The total score was 197 
summed and the studies were then ranked into groups of low quality (positive score in <2 198 
domains), fair quality (positive score in 2 domains), and good quality (positive score in 2 199 
domains). A further criterion was added that demonstrated whether the study had accounted 200 
for volume depletion due to dehydration following the exercise bout(s).  201 
 202 
Definition of Exercise Intensity. When available, the mean participant exercise heart rate 203 
(HR) was the parameter chosen to indicate the overall exercise intensity per study. Maximum 204 
HRs were not reported frequently enough in the literature to allow for the calculation of mean 205 
relative intensities. As all studies that reported HR data recruited trained participants only, in 206 
order to normalise the HR data as all exercise bouts involved either competitive or time-trial 207 
settings, we made the assumption that the mean HRs reported were reflective of the intensity 208 
demanded by the duration of the exercise bout. 209 
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2.4 Statistical Analysis 210 
 211 
2.4.1 Derivation of outcome statistics: Data were extracted from the studies independently 212 
by the first author. The key variables were E/A ratio and LVEF, with inter-individual SDs, as 213 
well as total cTn samples and positive cTn responses in each study. The dichotomous event 214 
rate for cTn response was defined as the number of participants exceeding the assay detection 215 
limit for the specific assay reported in the study. If available, the average exercise HR, 216 
exercise duration, participant age and mass were also extracted. If these data were not 217 
available, efforts were made to contact the authors of the paper to obtain them.  218 
 219 
2.4.2 Pooling of results: Data were analysed using the statistical software CMA (Biostat, 220 
Englewood, NJ). Standardised mean differences (Cohen’s d) with 95% CI’s were computed 221 
individually for E/A ratio and LVEF, and event rate was calculated for cTn positive results. 222 
The effect sizes were weighted according to the intra-study variability (calculated from 223 
reported means and SDs), with larger, more precise studies having a greater weighting on the 224 
overall effect size. Separate random-effects meta-analysis were run for each variable using 225 
CMA’s meta-regression function. This yielded the summary measures, significance levels 226 
(P), and the between-study heterogeneity (Cochran’s Q and I2) and variability (τ2). 227 
 228 
2.4.3 Exploration of publication bias: Publication bias was assessed via funnel plot 229 
inspection, with the expectation that studies would be evenly distributed between both sides 230 
of the average effect size, with high-precision studies close to the mean. The individual 231 
funnel plots are displayed in the supplementary material (Supplementary Figures 1-4). 232 
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Quantitative assessments of Kendall’s τ and Egger’s regression are also reported for all 3 233 
effect sizes alongside the funnel plots. 234 
 235 
2.4.4 Exploration of heterogeneity and meta-regression analyses: Heterogeneity of the 3 236 
effect sizes were assessed by Cochran’s Q and I2 values calculated in the random-effects 237 
model. Statistical significance for Q was p<0.01 and I2 of 25, 50 and 75% were interpreted as 238 
small, medium and large degrees of heterogeneity. In the event of significant levels of 239 
heterogeneity in any of the meta-analyses, exploratory meta-regression analyses were 240 
conducted to determine how participant and exercise characteristics accounted for 241 
heterogeneous effect sizes. The residual plots were inspected for suitability before reporting 242 
the R2 value of the fitted models. In the event of non-random residual plots, further variables 243 
were added to the model to capture possible significant interactions. All covariates were 244 
analysed separately and then together, to assess the individual contribution of each variable. 245 
A method of moment’s estimator for the between-study covariance matrix in the random 246 
effect models meta-regression was used. Two sub-group analysis were conducted, the first 247 
assessed troponin assay type vs. troponin event rates and five groups were formed for assay 248 
types: high-sensitivity cardiac troponin T and I (hs-cTnT and hs-cTnI; respectively), cardiac 249 
troponin T assays (cTnT), and cardiac troponin I assays manufactured by Beckman Coulter 250 
and Siemens (cTnI-Beckman and cTnI-Siemens; respectively). The effect of study exercise-251 
mode was also assessed, and three groups were formed, which were running, cycling and 252 
multisport. Following the meta-analysis of cTn event-rate, we matched the event rate from 253 
each study as a separate continuous moderator variable in the meta-analysis of E/A ratio and 254 
LVEF. 255 
 256 
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2.4.5 Sensitivity analysis: We conducted a sensitivity analysis by removing outlying studies. 257 
The duration of exercise in the study by Passaglia et al (32) was twice that of the next longest 258 
study and was removed from the analysis during the sensitivity analysis. However, no 259 
changes were noted following its exclusion, so it was left in the final analysis. 260 
 261 
3. Results 262 
 263 
The database search yielded 223 potential studies and after duplicates were removed 222 264 
remained. Studies involving chemical interventions, animal studies or in vivo methods were 265 
excluded, leaving 63 potential studies, which were further refined via the inclusion and 266 
exclusion criteria to 23 studies with 32 data sets (see PRISMA flow chart). 267 
 268 
3.1 Findings of the Systematic Review 269 
 270 
With the exceptions of the two studies by Chan-Dewar et al. (19, 20), all studies reported that 271 
exercise lead to a significantly reduced LVEF, E/A ratio, or both variables. There were five 272 
studies in total that reported significant reductions in both E/A ratio and LVEF (6, 10, 25, 26, 273 
27) and the study quality amongst these ranged from fair to good. For the detailed breakdown 274 
of the level of control applied in each study see Table 2 in the Supplementary file. 275 
It was apparent that only half of the studies in our data set made use of serial measurements 276 
of cardiac function and biomarker release into the recovery stages, with the remaining half 277 
relying upon single measurements taken immediately post-exercise to draw their conclusions. 278 
Of the studies that took serial measurements, three studies (1, 17, 28) performed repeated 279 
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measures for cTn and echocardiography at 6 hours post; three studies (17, 23, 31) only 280 
collected cTn samples at 24 hours, and six studies (1, 10, 11, 14, 24, 35) took both cTn and 281 
echocardiography at 24 hours; the study by Whyte et al. (6) took post-exercise blood and 282 
echo measurements at 48 hours post-exercise. The longest follow-up measurements were in 283 
the study of La Gerche et al., (27) who collected blood and LV functional data one-week 284 
post-exercise. Of the 24-hour follow-up measurements, all studies reported participants 285 
echocardiographic and cTn values returning to pre-exercise levels in all but one study (31), 286 
that reported elevated cTn in nine participants at the 24-hour point. Of the studies that took 287 
follow-up measurements at 6 hours post-exercise, E/A ratio and cTn remained elevated above 288 
pre-exercise values in three studies (1, 17, 28). Nie et al (26) reported that LV function had 289 
returned to baseline within 6 hours post-exercise but cTn remained elevated in the cohort.  290 
 291 
Only four of the 22 studies reported correlations with biochemical data and functional cardiac 292 
measurements. However, it is important to note that no studies reported any correlations 293 
between standard echocardiographic measurements and cTn release. Aagard and colleagues 294 
(21) reported that participants who demonstrated the greatest reductions in resting heart-rate 295 
variability also released the most cTn. La Gerche et al. (27) found significant (P<0.05) 296 
correlations between cTn release and myocardial deformation (R=0.45) and wall motion 297 
abnormalities (R = 0.77). Nie and colleagues (26) reported that endocardial strain reductions 298 
correlated with the magnitude of cTn release (R=0.7), and Tulloh and colleagues (31) 299 
reported immediate post-exercise resting cardiac output attenuated the greatest in the 300 
participants with the greatest post-exercise cTn release.  301 
 302 
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3.1.1 Fluid Loss. The monitoring of body mass loss during exercise did not appear to 303 
influence the echocardiographic or cTn data. Significant reductions in echocardiographic 304 
parameters were found in both monitored and non-monitored studies, and the detection of 305 
E/A ratio and LVEF changes was not influenced by weight loss monitoring.  306 
 307 
3.1.2 Blinding. The majority of studies did not blind the sonographer or technician, but these 308 
studies were not more likely to report reductions in the echocardiographic parameters after 309 
exercise. Three studies (10, 20, 35) reported the previously obtained intra-individual CV of 310 
their echocardiographic measurements to demonstrate reliability. 311 
 312 
3.1.3 Strain Imaging. There were six studies (1, 15, 19, 20, 23, 27) that reported LV or RV 313 
strain and strain rates. These variables were reported in limited and insufficient quantities 314 
across the 22 studies to facilitate a meta-analysis of the strain data. Exercise was shown to 315 
significantly reduce RV longitudinal strain (LS) in two studies (1, 27) that involved >60 316 
minutes of exercise, whereas RV LS was maintained in the study of Stewart et al (15), which 317 
involved <60 minutes of exercise. Longitudinal LV strain was significantly reduced in three 318 
studies (1, 19, 27), and unaffected following a 6 hour triathlon in the study of Leetmaa et al 319 
(23). The participants in this study were elite national-level triathletes and it is worth noting 320 
that the reported values were substantially higher than in all other studies (27.5% pre-321 
exercise, 26.8% post). Longitudinal strain was increased following the low-intensity exercise 322 
bout in Chan-Dewar et al (20), and maintained following <60 minutes of moderate intensity 323 
cycling in the studies of Stewart et al. (15) and Chan-Dewar et al. (19). Stewart and 324 
colleagues (15) reported large reductions in radial strain (RS) and a small, significant 325 
reduction in circumferential strain (CS), with no concomitant change in RS or CS rates. In 326 
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contrast, RS and CS rates were increased following the lower intensity exercise in the two 327 
studies of Chan-Dewar et al (19, 20). It would appear from these findings that cycling 328 
exercise of up to 60 minutes duration at low to moderate-intensities does not affect 329 
myocardial strain but high intensity cycling exercise of >60 minutes may negatively impact 330 
radial, circumferential and longitudinal strain. 331 
 332 
3.2 Results of the Meta-Analysis  333 
 334 
3.2.1 Tests of Heterogeneity: All three meta-analyses reported evidence of significant 335 
heterogeneity between the studies, justifying our use of the random-effects model. 336 
Additionally, in each analysis there were significant Tau squared values that indicated real 337 
differences in effect sizes, ruling out the likelihood of sampling or random errors and 338 
subsequent meta-regressions were carried out in each case (Table 1).  339 
 340 
3.2.2 Publication Bias Investigation: There was no sign of publication bias among the 3 341 
separate meta-analyses that were conducted. For each variable the funnel plot demonstrated a 342 
symmetrical distribution of SE about the mean that closely followed along the guidelines 343 
printed by the CMA software. The funnel plot highlighted the absence of clustering around 344 
the mean shown in more precise studies, and we can therefore infer an absence of publication 345 
bias among the studies meta-analysed. Further tests to explore publication bias also 346 
confirmed this was absent; Egger’s regression intercepts were non-significant and Kendall’s 347 
Τau reported a non-significant negative correlation of study size on logit event rate in each 348 
case. 349 
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3.2.3 Subgroup Analyses: There was no significant effect of exercise mode on the 350 
magnitude of effect sizes or event rates of the 3 variables. Subgroup analysis for each 351 
variable demonstrated significant heterogeneity when using the fixed-effects models 352 
therefore the findings of the mixed-effects model were used. The second subgroup analysis 353 
for cTn assay types found there was a significant effect of assay type on troponin event rate. 354 
The overall test of between subgroup heterogeneity was significant for the 5 assay groups (Q 355 
= 11.8, P = 0.019).  356 
 357 
3.2.4 Troponin Event Rates: The overall event rate, as calculated by the random-effects 358 
meta-analysis, for the detection of cTn was 45.6%, but not significant (95% CI [33.6, 58.2%], 359 
P = 0.494) (Figure 2). By assay type, the mean event rate for cTnT was 40% (95% CI [23.3, 360 
57.2], P = 0.21, n = 28); 87.9% for hs-cTnT (95% CI [79.0, 96.7%], P = 0.01, n = 4), 49.2% 361 
for hs-cTnI  (95% CI [26.6, 71.9%], P = 0.96, n = 3), 71.4% for cTnI-Beckman (95% CI 362 
[51.3, 91.5%], P = 0.58, n = 2), and 31.5% for cTnI-Siemens (95% CI [19.3, 43.7%], P = 363 
0.048, n = 5). 364 
 365 
3.2.5 E/A Ratio: Post-exercise E/A values were significantly (P < 0.001) reduced over pre-366 
exercise levels, the mean difference was –0.38 (SE = 0.041, 95%CI [-0.376, -0.307]) and the 367 
SMD (Cohen’s d) was -1.197 (95% CI [-1.401, -0.993]) (Figure 3). 368 
 369 
3.2.6 Left Ventricular Ejection Fraction: The mean difference in LVEF between pre and 370 
post-exercise values was -2.02% (SE = 0.568, 95%CI [-3.14, -0.91]), d = -0.44 (95%CI [-371 
0.74, -0.14]) (Figure 4).  372 
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3.3 Results of the Meta Regression 373 
 374 
3.3.1 Troponin Event Rate: Of the 32 data sets, 22 contained exercise HR and duration data, 375 
allowing for comparisons of exercise intensity and duration, as well as participant age and 376 
mass for inclusion into the regression analyses. For the reduced sample size of n=22, between 377 
study variance was similar to the original data set (see Table 1). Following univariate 378 
regression analyses, we found that post-exercise positive cTn response rate was influenced by 379 
increased exercise HR (intensity) and reduced age. The regression coefficient for HR 380 
predicted a 0.12 increase in logit event rate per 1 bmin-1 increase in HR (Figure 5A). 381 
Participant age was negatively associated with logit event rate (Figure 5B). The regression 382 
coefficient was -0.10 per increased year of age. Tests for remaining unexplained variance 383 
were significant for each covariate (P < 0.001), highlighting that cTn event rate still differed 384 
among studies reporting similar participant age and HR (Table 1). Using the 22 data sets that 385 
reported HR and duration, there was a significant effect of exercise on event rate despite a 386 
reduced overall event rate (logit event rate [95%CI] = 0.64 [-1.25, 0.01], P < 0.05). 387 
 388 
3.3.2 E/A Ratio: Of the 28 data sets containing E/A ratio data, 18 reported participant mass, 389 
age, exercise HR, and duration. Additionally, cTn event rate (%) was included as a covariate 390 
in the regression analyses. The results of the single covariate analyses can be seen in Table 1. 391 
We found that post-exercise positive cTn response rate was influenced by increased exercise 392 
HR and increased cTn event rate. The regression coefficient for HR predicted a 0.03 393 
reduction in E/A ratio SMD per 1 b·min-1 increase in HR (Figure 5C). Troponin event rate 394 
was negatively associated with E/A ratio, the regression coefficient was -0.01 for every 1 395 
percent increase in event rate (p< 0.05) (Figure 5D). 396 
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3.3.3 Left Ventricular Ejection Fraction: For the reduced sample size of n = 20, between 397 
study variance was similar to the original data set (see Table 1). We found no significant 398 
interaction of any of the moderator variables on effect size, despite there being potentially a 399 
large proportion of the variance explainable by study-level covariates, as indicated by I2 of 400 
80.3.  401 
 402 
 403 
 404 
 405 
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Table 1. Univariate and multivariate meta-regression analysis for cardiac troponin and E/A ratio. 406 
 
 Troponin Event Rate (logit)    E/A Ratio 
Model 
n ß (95% CI) 
Q 
I2 τ 2 R2 
 n ß (95% CI) Q 
I2 τ 2 R2 
Univariate 22  
85.6*** 75.5 1.43 - 
 
18 - 35.6*** 52.2 0.20 - 
HR 
22 0.118 (0.061, 0.175)*** 59.4*** 66.3 0.98 0.31 
 
18 -0.029 (-0.054, 0.004)* 27.67* 42.17 0.13 0.33 
Age 
22 -0.104 (-0.202, -0.005)* 80.3*** 75.1 1.46 0.02 
 
18 0.015 (-0.028, 0.059) 34.55** 53.69 0.21 -0.08 
Duration 
22 0.0003 (-0.006, 0.007) 84.8*** 76.4 2.00 0.00 
 
18 -0.002 (-0.006, 0.002) 34.00 52.94 0.21 -0.06 
Mass 
22 -0.054 (-0.125, 0.018) 80.83*** 75.3 1.49 0.00 
 
18 0.011 (-0.020, 0.042) 34.24* 53.27 0.21 -0.05 
Troponin 
22      
 
18 -0.010 (0.018-0.002)* 26.80* 40.3 0.12 0.37 
Multivariate 18 -22.82 (-33.90,-11.75) 20.60* 36.88 0.51 0.80  18 
2.32 (-6.3, 10.95) 
23.82 49.63 0.19 0.04 
HR  0.16*** (0.08, 0.19)       
0.01 (-0.09, 0.1) 
    
Age  -0.15* (-0.29, -0.04)       
-0.02 (-0.07, 0.03) 
    
Duration  0.02 (0.007, 0.010)       
0 (-0.06, 0.06) 
    
Mass  0.11 (-0.01, 0.17)       
-0.01 (-0.02, 0.01) 
    
 407 
ß = meta-regression coefficient, I2 = percentage of between study variation that is due to heterogeneity, τ2 = between study variance, Q-total = weighted sum of squared 408 
differences between individual study effect size and pooled effect size, R2 = Proportion of total variance explained by covariate model, negative values analogous to zero. * = 409 
P < 0.05, ** = P < 0.01, *** = P < 0.001 410 
 411 
20 
 
4. Discussion 412 
 413 
This is the first systematic review and meta-analysis to focus on the relationship between 414 
functional and biochemical indices of cardiac fatigue and damage. We exclusively analysed 415 
studies using the mixed methods of echocardiography and cardiac biomarkers to attempt to 416 
elucidate the relationship between them, and whether cTn release results in transient 417 
functional decrements (28, 34). To better inform endurance athletes, coaches and sports 418 
physicians, we also aimed to explore the relationship between exercise duration, mode and 419 
intensity in eliciting EICF and cTn release. The results of this study demonstrate that there is 420 
an overall reducing effect of prolonged, strenuous exercise on LV diastolic and systolic 421 
function, and confirm Shave and colleagues’ finding of a ~50% event rate of cTn release 422 
(33). Endurance exercise of durations ranging from 45 to 1440 minutes caused significant 423 
reductions in E/A ratio of -0.34 (d =-1.20, P < 0.001), and LVEF of -2.0% (d = -0.44, P = 424 
0.004). These findings agree with the previous meta-analysis performed by Middleton et al 425 
(4), who reported mean reductions in E/A ratio of 0.45 (-0.39, -0.51) and LVEF of -1.95% (-426 
1.03, -2.88%) immediately following endurance exercise of similar durations.  427 
 428 
4.1 Systematic Review 429 
 430 
The systematic review of the literature aimed to address the influence of study design on the 431 
reported outcome measures and to summarise the general findings of the previous works. A 432 
key finding was that very few total studies reported LVEF changes across the 22 studies and 433 
this may be a factor of the varied time course of systolic and diastolic functional alterations. 434 
In pathological conditions, diastolic functional changes occur before systolic (37) and it is 435 
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possible that following exercise, any systolic functional changes are realised later and 436 
potentially missed by the timing of testing protocols.  437 
 438 
Of relevance to future research is the finding that only ten of the studies took 439 
echocardiographic measurements immediately prior to exercise. To account for variations in 440 
loading conditions and hydration status that influence echocardiographic measurements, it is 441 
recommended that pre-exercise measurements be taken as close as possible to the start of 442 
exercise (34). Our finding that over half of the sampled studies made inferences about post-443 
exercise cardiac function from potentially inaccurate pre-exercise values should be a future 444 
consideration and may assist in explaining the dearth of previously reported correlations 445 
between cTn concentration and functional cardiac parameters. Furthermore, only half of the 446 
22 studies performed serial follow-up measurements to assess the recovery of the 447 
participants. The remaining eleven studies performed echocardiographic and cTn 448 
measurements immediately after exercise, which may have influenced the post-exercise 449 
readings through mechanisms such as post-exercise tachycardia, hypotension and volume 450 
depletion. Although, to account for such factors a level of control was applied in each study 451 
that performed only immediate post-exercise measures, either statistically or via fluid 452 
replacement to attempt to restore loading conditions. A single post-exercise blood sample 453 
may have missed the peak cTn values, which was reported to occur at 6 hours post-exercise 454 
in three of the studies that performed follow-up measures. Two studies (1, 17) also examined 455 
the time course of LV functional changes across several time points during the acute recovery 456 
period, and only the study by Tian et al. (17) reported significant reductions in LVEF at the 457 
6-hour post-exercise time point, that were not evident immediately after exercise. Therefore, 458 
it is apparent that the quality of half of the reviewed studies suffered from not incorporating 459 
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multiple time points during the post-exercise data collection periods and by not performing 460 
echocardiographic assessments closer to the beginning of exercise.  461 
 462 
4.2 Meta-Analysis 463 
 464 
4.2.1 Effect of Exercise Intensity 465 
 466 
We found that exercise HR was the strongest predictor of cTn event rate (R2 = 0.31). This 467 
current finding of increased cTn event rates with increasing exercise HR supports the theory 468 
that cTn release is intensity-dependent and the notion that the rate and force of myocyte 469 
contraction influences cTn release. It has been suggested that post-exercise cTn release 470 
occurs due to membrane damage caused by increased mechanical force of cardiac 471 
myofibrillar contraction (34). In the absence of ischaemia, the transport of intact cTn 472 
molecules is potentially mediated by excessive stretch of myofibrils stimulating integrin-473 
mediated transport (38). Troponin I degradation in the absence of ischaemia has been shown 474 
to increase with LV preload in the rat model (39). Additionally, increased membrane 475 
permeability resulting from oxidative damage and inflammation subsequent to intense 476 
exercise may allow cTn release (40). Whether this cTn is bound to the myocardium or stored 477 
in the cytoplasm remains to be determined. Figure 6 presents a plausible mechanism for 478 
troponin transport from the myocardium to the peripheral circulation. It is therefore plausible 479 
that both intact and degraded cTn products found in serum post-exercise originate from 480 
viable cardiomyocytes, due to the increased preloads generated during exercise. 481 
 482 
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If thresholds of exercise intensity, rather than duration exist at which cTn is released, these 483 
may be altered following positive cardiac adaptations that establish improved fitness levels. 484 
Unfortunately, it was not possible to separate the cases based on training status in the present 485 
study owing to a lack of data. Whether cTn release following exercise is an adaptive response 486 
that elicits improved cardiac function and a reduced threshold for future cTn release remains 487 
to be thoroughly examined.  488 
 489 
Higher exercise HRs increased the magnitude of the post-exercise alteration in LV diastolic 490 
filling. In most cases, this was due to a reduction in peak early (E) and maintenance of peak 491 
late (A) transmitral filling velocity, which is associated with increased heart rates and reduced 492 
ventricular filling times (34). Potential mechanisms responsible for altered LV relaxation, in 493 
addition to prolonged elevated HRs, include downregulation of cardiac ß-adrenoceptors 494 
mediated by elevated catecholamines during exercise (42). In fact, circulating catecholamines 495 
are responsible for maintaining tachycardia during endurance exercise and Breuer et al. (41) 496 
have shown that concentrations of plasma catecholamines increase with exercise HR. 497 
Alterations in adrenergic responsiveness following exercise were reported by Eysmann and 498 
colleagues (42) in both Ironman athletes and healthy sedentary individuals, and these changes 499 
were correlated with declines in LV function. However, it remains to be seen how differential 500 
modulation of the autonomic nervous system, prolonged heart rates, and substrate circulation 501 
factor in the development of EICF (36, 42, 43). Our data support the hypothesised 502 
relationship between altered myocardial relaxation and decreased sensitivity of ß-503 
adrenoceptors induced by increasing circulating catecholamines ubiquitous to higher exercise 504 
HRs during prolonged strenuous exercise (44, 45). 505 
 506 
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4.2.2 Effect of Exercise Mode 507 
 508 
Our sub group analyses did not identify any differences between exercise mode in contrast to 509 
the findings of Shave et al. (33) who reported that running stimulated greater cTn release 510 
compared to cycling. While the fixed effects model returned a significant effect of exercise 511 
mode, our accompanying tests of heterogeneity did not fulfil the assumptions of the model. It 512 
has been hypothesised that running exercise elicits higher HRs than cycling due to greater 513 
V
·
O2 requirements, recruitment of the upper body musculature and accessory muscles, and the 514 
lack of postural support during cycling (46). Additionally, modal differences in cTn release 515 
may be explained by attaining higher absolute cardiac and metabolic work rates during 516 
running (46, 47). In our data, average cycling HR was 150 vs. 156 bmin-1 in running. It is not 517 
possible to compare with the previously published meta-analysis as HR data were unavailable 518 
in the studies analysed by Shave and colleagues (33).  519 
 520 
4.2.3 Effect of Exercise Duration 521 
 522 
We found no significant effect of exercise duration on either cTn release, LV systolic or 523 
diastolic function. When the exercise protocols employed in PSE studies typically involve a 524 
maximal race-effort, exercise duration dictates exercise intensity. Previous meta-analyses 525 
have failed to investigate the role of exercise HR and have concentrated on duration; 526 
therefore, no comparable data exists. The absence of a significant effect of exercise duration 527 
on either cTn release or EICF contradict the meta-analyses by Shave et al. (33) and 528 
Middleton et al. (4) despite inclusion of a similar amount of studies, cases and participant 529 
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characteristics. The previous meta-analysis of cTn event rates did not report regression 530 
coefficients for significant moderators and also used a fixed-effects meta-regression. This 531 
may not have been appropriate, depending on the level of heterogeneity between studies in 532 
the model as we encountered significant heterogeneity at the study level in all 3 meta-533 
analyses. In our review, this meant that the true effect size likely differed between studies at 534 
similar levels and use of the fixed-effects model would not be appropriate.  535 
 536 
4.2.4 Participant Age 537 
 538 
We found that participant age was negatively associated with troponin event rate and we also 539 
observed a significant (P<0.05) negative correlation between age and HR, indicating that 540 
older participants do not achieve higher HRs during exercise. The attainment of higher levels 541 
of cardiac work during exercise may therefore be a crucial role in the development of 542 
exercise troponin release, as previously indicated. Conversely, the level of training previously 543 
achieved may be responsible for reduced cTn event rates with increased age, and it may be 544 
that lifelong athletes develop greater thresholds to cTn release than younger, less-trained 545 
counterparts. Without training history data, this phenomenon cannot be investigated via meta-546 
analytical methods.  547 
 548 
4.2.5 Troponin Event Rate Affects Diastolic Function 549 
 550 
Our data demonstrated a significant relationship between the E/A ratio and cTn release, 551 
wherein the reduction in E/A ratio was related to the magnitude of cTn positive event rates. 552 
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This finding is contradictory to the majority of research as few individual studies have 553 
reported correlations between any LV functional indices and cTn release. When loading 554 
conditions such as resting heart rate and plasma volume are controlled for, exercise induced 555 
diastolic functional changes are likely to be caused by reductions in myocardial relaxation. 556 
While the mechanistic basis for altered relaxation are yet to be fully determined, increased 557 
cardiomyocyte membrane permeability has been suggested as a factor in this, as well as cTn 558 
release (9). Although individual studies rarely find significant correlations between the two 559 
(12), it may be the case that this was due to insufficient sample sizes to bear out the 560 
underlying relationships and the larger sample sizes meta-analysed in this study addressed 561 
this limitation. 562 
 563 
4.3 Limitations 564 
 565 
Inconsistent timing of the post-exercise echocardiograms and blood samples across the range 566 
of studies may have had severe effects on the values we analysed. Mechanisms responsible 567 
for this include the time-course of cTn release, which is thought to peak at approximately 568 
3hrs post-exercise (12). To control for this variability, we selected studies that obtained blood 569 
values within 1hr of the cessation of exercise, and it was apparent from the findings of the 570 
systematic review that only a limited amount of studies performed follow-up measurements 571 
beyond 1 hour after exercise. Additionally, an important limitation was the inclusion of 572 
studies that measured both troponin I and T. Troponin I is thought to be less sensitive than 573 
troponin T due to several manufacturers producing assays for it (33). Our sub-group analysis 574 
to determine a significant effect of assay type on troponin event rate found that there were 575 
significant differences between all assay types, yet there was significant variation and 576 
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heterogeneity among the 5 sub-groups. The intrinsically high levels of variation amongst the 577 
sample sizes in terms of study design, exercise characteristics, and participant variables 578 
therefore mean that the influence of assay type on event rate prevalence may come secondary 579 
to other such factors. Previous studies measuring both high sensitivity troponin T and I have 580 
demonstrated the assays to perform comparably in diagnostic performance in a clinical 581 
population, and these are currently the recommended assay-type for cardiac damage 582 
diagnosis (48). Echocardiographic variables may be influenced by the timing of post-exercise 583 
echocardiograms as loading conditions are altered by blood plasma shifts during and after 584 
exercise. Further, the influence of post-exercise hypotension and augmented autonomic 585 
modulation during the recovery from exercise should not be overlooked. Stewart and 586 
colleagues (1) demonstrated by using more sensitive echocardiographic techniques that when 587 
loading and functional requirements are equal to pre-exercise levels, demonstrably greater 588 
differences in LV and RV function exist post-exercise. Additionally, the lack of availability 589 
of RV data is a key limitation to the implications that can be made from our data, as this 590 
chamber has shown to be more susceptible to fatigue in athletes (27). 591 
While we found evidence of a significant effect of cTn release with altered diastolic filling, 592 
our data are merely correlational. There is insufficient physiological data present in the 593 
original studies to determine a causal relationship. In addition, a comprehensive approach in 594 
the assessment of diastolic function is required in future research to confirm whether diastolic 595 
dysfunction is present in athletes following exercise, including tissue Doppler imaging, left 596 
atrial volume, LV twist/untwist velocities, and global strain and strain rate imaging to support 597 
this association (1).  598 
 599 
 600 
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4.4 Conclusion 601 
 602 
The novel findings of the meta-analysis established exercise intensity, measured via average 603 
absolute exercise HR, as the predominant factor in causing reduced diastolic function and 604 
cTn release. Our finding supports the theory that cTn release and EICF are intensity-605 
dependent as our data did not show a significant effect of duration on any of the cardiac 606 
variables. The second novel finding was that increased troponin event rates were positively 607 
associated with greater reductions in mitral E/A ratio, which supports the theory that EICF 608 
and cTn release are related. The low to moderate R2 values related to exercise HR and cTn 609 
event rate (0.33 and 0.37; respectively. See Table 1) leave a remaining portion of the 610 
calculated variance requiring further exploration. Future work should aim to investigate these 611 
relationships further, using more specific tissue Doppler measurements of diastolic function, 612 
and potentially by employing standardised exercise challenges to normalise cardiac function 613 
before and after PSE (1).  614 
 615 
Finally, our finding of a significant negative effect of participant age on cTn event rates 616 
indicates that longer-term athletes may be less prone to cTn release as a result of cardiac 617 
adaptations pursuant to life-time training volumes (49), challenging the theory that cTn 618 
release is related to permanent cardiac injury (50). Future research into the effects of aging on 619 
cardiac adaptation to exercise may wish to investigate the characteristics of cTn release 620 
following exercise in life-long endurance athletes compared to younger, highly-trained 621 
athletes.  622 
  623 
 624 
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Figure Legends 812 
 813 
Figure 1: PRISMA flow chart. 814 
 815 
Figure 2: Forest plot showing logit event rate (solid squares) and 95%CI limits (solid 816 
horizontal lines) for each study. The studies are ranked with ascending magnitude of event 817 
rate, by exercise mode sub-groups. The overall random-effects logit event rate is shown in the 818 
bottom row (solid diamond). The – symbol indicates data that were unavailable. A logit event 819 
rate of 0 corresponds to an event rate of 50%, a negative logit event rate indicates a frequency 820 
of troponin release from less than 50% of the participants within the study. 821 
 822 
Figure 3: Forest plot showing standardised mean differences (SMD, Cohen’s d) between pre 823 
and post exercise values of the E/A ratio (early to late peak transmitral velocity flow) (solid 824 
squares) and 95%CI limits (solid horizontal lines) for each study. The studies are ranked with 825 
ascending magnitude of event rate, by exercise mode sub-groups. The overall random-effects 826 
SMD is shown in the bottom row (solid diamond). The – symbol indicates data that were 827 
unavailable.  828 
 829 
Figure 4: Forest plot of standardised mean differences (SMD, Cohen’s d) between pre/post 830 
exercise ejection fraction (solid squares) and 95%CI limits (solid horizontal lines) for each 831 
study. The studies are ranked with ascending magnitude of event rate, by exercise mode sub-832 
groups. The overall random-effects logit event rate is shown in the bottom row (solid 833 
diamond). The – symbol indicates data that were unavailable. 834 
 835 
Figure 5: Random-effects univariate meta-regression A) HR on troponin event rates showing 836 
the positive relationship between increased exercise intensity and troponin release, B) 837 
Participant age on troponin event rates showing the negative relationship between increased 838 
age and troponin release, C) Average HR on E/A ratio SMD (d) showing greater reductions 839 
in E/A ratio occur as exercise HR increases, D) Percentage of participants per study who 840 
exceeded the troponin assay limit of detection vs the standardised differences in E/A ratio (d) 841 
following exercise, indicating that E/A ratio is reduced to a greater extent in studies with 842 
higher rates of troponin release. Each circle represents a study and the size of the circle 843 
reflects the influence of that study on the model. The regression prediction is represented by 844 
the solid line.  845 
 846 
Figure 6: Exercise intensity and age influence myocardial diastolic function and cardiac 847 
troponin release.  848 
 849 
Table 1: Univariate and multivariate meta-regression analyses for cardiac troponin and E/A 850 
ratio. 851 
